Drugs / RO7812653
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07234942 | Jan 2026 → Apr 2028 expected | Alzheimer disease | Hoffmann-La Roche | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7812653 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07234942 ↗ |
| Route | Intrathecal | “Following Intrathecal Administration in Participants With Early Symptomatic Alzheimer's Disease” NCT07234942 ↗ |